paclitaxel derivatives (Elan)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepaclitaxel derivatives (Elan)
Drug Alias NameBrC16HTpaclitaxel derivatives (Liposome Company)BRT-216C16HTD
ClassificationSmall molecules
Mechanisms of ActionMicrotubule stabilizer
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Liposome Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A